The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...
Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...
While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...
Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.
As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...
While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...
COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during ...
The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...
Doctor visits for RSV are at a "very high" level in Mississippi. Health officials provide warning signs of RSV to look for in ...
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...